Pinelopi Anagnostopoulou

Dr. Pinelopi Anagnostopoulou


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
PAPinelopi Anagnostopoulou
Pinelopi Anagnostopoulou
BRBrigitte Riederer
Brigitte Riederer
JDJulia Duerr
Julia Duerr
SMSven Michel
Sven Michel
ABAristea Binia
Aristea Binia
MMMarcus A. Mall
Marcus A. Mall
Asthma is a chronic condition with unknown pathogenesis, and recent evidence suggests that enhanced airway epithelial chloride (Cl–) secretion plays a role in the disease. However, the molecular mechanism underlying Cl– secretion and its relevance in asthma pathophysiology remain unknown. To determine the role of the solute carrier family 26, member 9 (SLC26A9) Cl– channel in asthma, we induced Th2-mediated inflammation via IL-13 treatment in wild-type and Slc26a9-deficient mice and compared the effects on airway ion transport, morphology, and mucus content. We found that IL-13 treatment increased Cl– secretion in the airways of wild-type but not Slc26a9-deficient mice. While IL-13–induced mucus overproduction was similar in both strains, treated Slc26a9-deficient mice exhibited airway mucus obstruction, which did not occur in wild-type controls. In a study involving healthy children and asthmatics, a polymorphism in the 3′ UTR of SLC26A9 that reduced protein expression in vitro was associated with asthma. Our data demonstrate that the SLC26A9 Cl– channel is activated in airway inflammation and suggest that SLC26A9-mediated Cl– secretion is essential for preventing airway obstruction in allergic airway disease. These results indicate that SLC26A9 may serve as a therapeutic target for airway diseases associated with mucus plugging.

20 December 2019 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
PAPinelopi Anagnostopoulou
Pinelopi Anagnostopoulou
PLPhilipp Latzin
Philipp Latzin
RJRenee Jensen
Renee Jensen
MSMirjam Stahl
Mirjam Stahl
AHAlana Harper
Alana Harper
KRKathryn A. Ramsey
Kathryn A. Ramsey
Background: The multiple breath nitrogen washout (N2MBW) technique is increasingly used to assess the degree of ventilation inhomogeneity in school-aged children with lung disease. However, reference values for healthy children are currently not available. The aim of this study was to generate reference values for N2MBW outcomes in a cohort of healthy Caucasian school-aged children.Methods: N2MBW data from healthy Caucasian school-age children between 6 and 18 years old were collected from four experienced centres. Measurements were performed using an ultrasonic flowmeter (Exhalyzer D, Eco Medics AG, Duernten, Switzerland) and were analysed with commercial software (Spiroware version 3.2.1, Eco Medics AG). Normative values and upper limits of normal (ULN) were generated for lung clearance index (LCI) at 2.5% (LCI2.5%) and at 5% (LCI5%) of the initial nitrogen concentration and for moment ratios (M1/M0and M2/M0). A prediction equation was generated for functional residual capacity (FRC).Results: Analysis used 485 trials from 180 healthy Caucasian children aged from 6 to 18 years old. While LCI increased with age, this increase was negligible (0.04 units·year–1for LCI2.5%) and therefore fixed ULN were defined for this age group. These limits were 7.91 for LCI2.5%, 5.73 for LCI5%, 1.75 for M1/M0and 6.15 for M2/M0, respectively. Height and weight were found to be independent predictors of FRC.Conclusion: We report reference values for N2MBW outcomes measured on a commercially available ultrasonic flowmeter device (Exhalyzer D, Eco Medics AG) in healthy school-aged children to allow accurate interpretation of ventilation distribution outcomes and FRC in children with lung disease.

22 April 2010 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
PAPinelopi Anagnostopoulou
Pinelopi Anagnostopoulou
LDL. Dai
L. Dai
JSJ. Schatterny
J. Schatterny
SHS. Hirtz
S. Hirtz
JDJulia Duerr
Julia Duerr
MMM.A. Mall
M.A. Mall
The airway epithelium is a central effector tissue in allergic inflammation and T-helper cell (Th) type 2-driven epithelial responses, such as mucus hypersecretion contribute to airflow obstruction in allergic airway disease. Previousin vitrostudies demonstrated that Th2 cytokines also act as potent modulators of epithelial ion transport and fluid secretion, but thein vivoeffect of allergic inflammation on airway ion transport remains unknown.We, therefore, induced allergic inflammation by intratracheal instillation ofAspergillus fumigatusextract or interleukin-13 in mice and determined effects on ion transport in native tracheal and bronchial tissues.We demonstrate that allergic inflammation enhanced basal Cl-secretion in both airway regions and inhibited epithelial Na+channel (ENaC)-mediated Na+absorption and increased Ca2+-dependent Cl-secretion in bronchi. Allergen-induced alterations in bronchial ion transport were associated with reduced transcript levels of α-, β- and γENaC, and were largely abrogated in signal transducer and activator of transcription (Stat)6-/-mice.Our studies demonstrate that Th2-dependent airway inflammation produced a pro-secretory ion transport phenotypein vivo, which was largely Stat6-dependent. These results suggest that Th2-mediated fluid secretion may improve airway surface hydration and clearance of mucus that is hypersecreted in allergic airway diseases such as asthma, and identify epithelial Stat6 signalling as a potential therapeutic target to promote mucus hydration and airway clearance.

18 August 2015 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
PAPinelopi Anagnostopoulou
Pinelopi Anagnostopoulou
SYSophie Yammine
Sophie Yammine
ASAnne Schmidt
Anne Schmidt
IKInsa Korten
Insa Korten
EKElisabeth Kieninger
Elisabeth Kieninger
PLPhilipp Latzin
Philipp Latzin

9 November 2017 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
EKElisabeth Kieninger
Elisabeth Kieninger
SYSophie Yammine
Sophie Yammine
IKInsa Korten
Insa Korten
PAPinelopi Anagnostopoulou
Pinelopi Anagnostopoulou
FSFlorian Singer
Florian Singer
PLPhilipp Latzin
Philipp Latzin
It is not known at what age lung function impairment may arise in children with cystic fibrosis (CF). We assessed lung function shortly after birth in infants with CF diagnosed by newborn screening.We performed infant lung function measurements in a prospective cohort of infants with CF and healthy controls. We assessed lung clearance index (LCI), functional residual capacity (FRC) and tidal breathing parameters. The primary outcome was prevalence and severity of abnormal lung function (±1.64 z-scores) in CF.We enrolled 53 infants with CF (mean age 7.8 weeks) and 57 controls (mean age 5.2 weeks). Compared to controls, LCI and FRC were elevated (mean difference 0.30, 95% CI 0.02–0.60; p=0.034 and 14.5 mL, 95% CI 7.7–21.3 mL; p<0.001, respectively), while ratio of time to peak tidal expiratory flow to expiratory time was decreased in infants with CF. In 22 (41.5%) infants with CF, either LCI or FRC exceeded 1.64 z-scores; three infants had both elevated LCI and FRC.Shortly after birth, abnormal lung function is prevalent in CF infants. Ventilation inhomogeneity or hyperinflation may serve as noninvasive markers to monitor CF lung disease and specific treatment effects, and could thus be used as outcome parameters for future intervention studies in this age group.

15 March 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PKPanayiotis Kouis
Panayiotis Kouis
AMAntonis Michanikou
Antonis Michanikou
PAPinelopi Anagnostopoulou
Pinelopi Anagnostopoulou
EGEmmanouil Galanakis
Emmanouil Galanakis
EMEleni Michaelidou
Eleni Michaelidou
PYPANAYIOTIS YIALLOUROS
PANAYIOTIS YIALLOUROS
Between March and April 2020, Cyprus and Greece health authorities enforced three escalated levels of public health interventions to control the COVID-19 pandemic. We quantified compliance of 108 asthmatic schoolchildren (53 from Cyprus, 55 from Greece, mean age 9.7 years) from both countries to intervention levels, using wearable sensors to continuously track personal location and physical activity. Changes in ‘fraction time spent at home’ and ‘total steps/day’ were assessed with a mixed-effects model adjusting for confounders. We observed significant mean increases in ‘fraction time spent at home’ in Cyprus and Greece, during each intervention level by 41.4% and 14.3% (level 1), 48.7% and 23.1% (level 2) and 45.2% and 32.0% (level 3), respectively. Physical activity in Cyprus and Greece demonstrated significant mean decreases by − 2,531 and − 1,191 (level 1), − 3,638 and − 2,337 (level 2) and − 3,644 and − 1,961 (level 3) total steps/day, respectively. Significant independent effects of weekends and age were found on ‘fraction time spent at home’. Similarly, weekends, age, humidity and gender had an independent effect on physical activity. We suggest that wearable technology provides objective, continuous, real-time location and activity data making possible to inform in a timely manner public health officials on compliance to various tiers of public health interventions during a pandemic.